deltatrials
Completed OBSERVATIONAL NCT05338762

TekiTrust Tests to Determine the Level of SARS-COV-2/COVID-19 Neutralizing Antibodies in the Blood

Clinical Agreement Study of 'TekiTrustTM SARS-CoV-2 Neutralizing Antibody Detection ELISA Kit' and 'TekiTrustTM SARS-CoV-2 Neutralizing Antibody Detection Rapid Test'

Sponsor: MiCo BioMed Co., Ltd.

Conditions SARS-CoV2 Infection
Updated 4 times since 2022 Last updated: Aug 8, 2022 Started: Jun 2, 2021 Primary completion: Nov 15, 2021 Completion: Aug 3, 2022
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on SARS-CoV2 Infection, this trial is completed. The trial is conducted by MiCo BioMed Co., Ltd. and has accumulated 4 data snapshots since 2021. Infectious disease trials contribute critical data for public health response and treatment development.

Status Flow

~May 2022 – ~Sep 2022 · 4 months · monthly snapshotRecruiting~Sep 2022 – ~Jul 2024 · 22 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

4 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed

  2. Jul 2024 — Sep 2024 [monthly]

    Completed

  3. Sep 2022 — Jul 2024 [monthly]

    Completed

    Status: Recruiting → Completed

  4. May 2022 — Sep 2022 [monthly]

    Recruiting

    First recorded

Jun 2021

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • MiCo BioMed Co., Ltd.
  • Syntactx
Data source: MiCo BioMed Co., Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations